Sina Nassiri
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
FAP-CD40 and PD1-IL2v combination therapy reprograms immunologically cold tumors through de novo intratumoral T cell-dendritic cell clusters.
Journal: Journal for immunotherapy of cancer
Published: May 14, 2026
Inhibition of anti-tumor immunity by melanoma cell-derived Activin-A depends on STING.
Journal: Frontiers in immunology
Published: November 08, 2023
Mcadet: A feature selection method for fine-resolution single-cell RNA-seq data based on multiple correspondence analysis and community detection.
Journal: PLoS computational biology
Published: November 01, 2023
Fibrotic response to anti-CSF-1R therapy potentiates glioblastoma recurrence.
Journal: Cancer cell
Published: June 21, 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 02, 2022
Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.
Journal: Nature cardiovascular research
Published: May 23, 2022
Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma.
Journal: Journal for immunotherapy of cancer
Published: April 04, 2022
Last Updated: 09/26/2026